Clinical characteristics and treatment-related biomarkers associated with response to high-dose interleukin-2 in metastatic melanoma and renal cell carcinoma: retrospective analysis of an academic community hospital’s experience

BACKGROUND: Immunotherapy in the treatment of metastatic melanoma and renal cell carcinoma can produce durable therapeutic responses, which may improve survival. We aimed to identify clinical characteristics and biomarkers associated with response to high-dose interleukin-2 therapy (IL-2) in patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Saraceni, Christine, Agostino, Nicole, Weiss, Michael J, Harris, Katherine, Nair, Suresh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4366439/
https://www.ncbi.nlm.nih.gov/pubmed/25815245
http://dx.doi.org/10.1186/s40064-015-0890-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4366439/
https://www.ncbi.nlm.nih.gov/pubmed/25815245
http://dx.doi.org/10.1186/s40064-015-0890-1

Ejemplares similares